Characterization of Novel PI3KÎ´ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies-Reference-Cited by-同舟云学术

Characterization of Novel PI3KÎ´ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies

Published:2014-05-22 Issue: Volume:5 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Haselmayer Philipp,Camps Montserrat,Muzerelle Mathilde,El Bawab Samer,Waltzinger Caroline,Bruns Lisa,Abla Nada,Polokoff Mark A.,Jond-Necand Carole,Gaudet MarilÃ¨ne,Benoit Audrey,Bertschy Meier Dominique,Martin Catherine,Gretener Denise,Lombardi Maria Stella,Grenningloh Roland,Ladel Christoph,Petersen JÃ¸rgen SÃ¸berg,Gaillard Pascale,Ji Hong

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. Systemic lupus erythematosus;Tsokos;N Engl J Med,2011

2. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions;Ortega;Lupus,2010

3. Belimumab: review of use in systemic lupus erythematosus;Boyce;Clin Ther,2012

4. Synthesis and function of 3-phosphorylated inositol lipids;Vanhaesebroeck;Annu Rev Biochem,2001

5. Taming the PI3K team to hold inflammation and cancer at bay;Hirsch;Pharmacol Ther,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition;Translational Oncology;2024-05

2. Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12

3. Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib;International Journal of Toxicology;2023-09-04

4. Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus;Frontiers in Immunology;2023-05-10

5. Tuning the Biological Activity of PI3Kδ Inhibitor by the Introduction of a Fluorine Atom Using the Computational Workflow;Molecules;2023-04-17